2 research outputs found
Photoresponse of a Single Y‑Junction Carbon Nanotube
We report investigation of optical
response in a single strand of a branched carbon nanotube (CNT), a
Y-junction CNT composed of multiwalled CNTs. The experiment was performed
by connecting a pair of branches while grounding the remaining one.
Of the three branch combinations, only one combination is optically
active which also shows a nonlinear semiconductor-like <i>I</i>–<i>V</i> curve, while the other two branch combinations
are optically inactive and show linear ohmic <i>I</i>–<i>V</i> curves. The photoresponse includes a zero-bias photocurrent
from the active branch combination. Responsivity of ≈1.6 mA/W
has been observed from a single Y-CNT at a moderate bias of 150 mV
with an illumination of wavelength 488 nm. The photoresponse experiment
allows us to understand the nature of internal connections in the
Y-CNT. Analysis of data locates the region of photoactivity at the
junction of only two branches and only the combination of these two
branches (and not individual branches) exhibits photoresponse upon
illumination. A model calculation based on back-to-back Schottky-type
junctions at the branch connection explains the <i>I</i>–<i>V</i> data in the dark and shows that under
illumination the barriers at the contacts become lowered due to the
presence of photogenerated carriers
Naturally Occurring Carbazole Alkaloids from <i>Murraya koenigii</i> as Potential Antidiabetic Agents
This study identified koenidine (<b>4</b>) as a metabolically
stable antidiabetic compound, when evaluated in a rodent type 2 model
(leptin receptor-deficient <i>db/db</i> mice), and showed
a considerable reduction in the postprandial blood glucose profile
with an improvement in insulin sensitivity. Biological studies were
directed from the preliminary in vitro evaluation of the effects of
isolated carbazole alkaloids (<b>1</b>–<b>6</b>) on glucose uptake and GLUT4 translocation in L6-GLUT4<i>myc</i> myotubes, followed by an investigation of their activity (<b>2</b>–<b>5</b>) in streptozotocin-induced diabetic
rats. The effect of koenidine (<b>4</b>) on GLUT4 translocation
was mediated by the AKT-dependent signaling pathway in L6-GLUT4<i>myc</i> myotubes. Moreover, in vivo pharmacokinetic studies
of compounds <b>2</b> and <b>4</b> clearly showed that
compound <b>4</b> was 2.7 times more bioavailable than compound <b>2</b>, resulting in a superior in vivo efficacy. Therefore, these
studies suggested that koenidine (<b>4</b>) may serve as a promising
lead natural scaffold for managing insulin resistance and diabetes